SEC Filing Analysis: IQVIA HOLDINGS INC. (IQV)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chairman & CEO of IQVIA received a routine grant of Stock Appreciation Rights (SARs) as part of his compensation package, representing a negligible percentage of the company's outstanding shares.
• Market Impact: Neutral. This transaction is a standard corporate governance action and is not expected to influence the stock price.

Company Information

Field	Value
Company	IQVIA HOLDINGS INC.
Ticker Symbol	IQV
CIK	0001478242
Industry	Commercial Physical & Biological Research

Insider Information

Field	Value
Name	BOUSBIB ARI
CIK	0001184180
Title/Position	Chairman, Chief Executive Officer & President
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-02-09
Transaction Code	A (Grant)
Security Type	Stock Appreciation Right
Shares Involved	78,264
Price Per Share	$0.00
Total Value	$0
Shares Owned After	78,264 (SARs)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted	78,264 (underlying shares)
% of Shares Outstanding	0.046%
Post-Transaction Ownership	78,264 SARs
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: As a large-cap company with a market capitalization of $31.93 billion, this equity grant is immaterial in size and financial impact.
• Ownership Concentration: This grant establishes a new derivative holding for the insider and does not significantly alter the overall ownership structure of the company.
• Dilution Impact: The potential dilution from the exercise of these 78,264 SARs is approximately 0.046% of shares outstanding, which is a negligible impact for existing shareholders.
• Transaction Significance: The transaction's value is $0 and it represents a very small fraction of the company's shares outstanding, confirming its low significance. It is a standard component of executive compensation.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants to executives are routine, pre-planned compensation events. They do not signal new information about the company's performance and are not considered market-moving.

Volume & Sentiment

• Expected Volume Impact: None. This is a non-market transaction and will not directly impact trading volume.
• Sentiment Indicator: Neutral. The market generally views standard executive compensation grants as a normal course of business.

Additional Context

Transaction Notes

• Vesting Schedule: The filing notes that the stock appreciation rights vest in three annual installments, beginning one year after the grant date (February 9, 2027). This structure is designed to retain the executive and align their interests with long-term shareholder value.